Titan Pharmaceuticals adds board member
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Titan Pharmaceuticals Inc. added Federico Seghi Recli to its board of directors.
Seghi Recli was also selected as lead director for Titan's board.
South San Francisco-based Titan Pharmaceuticals develops and sells therapeutics mainly for chronic diseases.